Carl Harald Janson
Director/Board Member at Aprea Personal AB
Network origin in Carl Harald Janson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Karolinska Institutet
9
| College/University | Other Consumer Services | 9 |
| Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 9 | |
Carnegie Fond AB
 Carnegie Fond AB Investment ManagersFinance Carnegie Fond AB (CF) is a wholly-owned subsidiary of Carnegie Investment Bank AB, in turn a wholly-owned subsidiary of the Stockholm-based financial group D.Carnegie & Co AB (ST: CAR). CF is located in Stockholm. The firm is a fund management specialist. They manage mutual funds for the parent group and sub-advise portfolios for third-parties. CF cooperates closely with their fellow subsidiary Carnegie Asset Management AB.
7
| Extinct | Investment Managers | 7 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.
6
| Operating Division | Investment Managers | 6 |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest.
4
| Subsidiary | Investment Managers | 4 |
KCIF Fund Management AB
3
| Subsidiary | 3 | |
Aprea Personal AB
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carl Harald Janson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Lannebo Fonder AB
 Lannebo Fonder AB Investment ManagersFinance Lannebo Fonder AB (Lannebo) is an independent fund management firm headquartered in Stockholm, Sweden. The firm was founded in 2000 by Anders Lannebo together with a group of portfolio managers from fund management companies of Nordic banks. Lannebo manages a range of Swedish mutual funds for individuals and institutional clients. Lannebo Fonder is a socially responsible investor and a signatory to the United Nations-supported Principles for Responsible Investment (UNPRI). | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet Holding AB
 Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Investment Trusts/Mutual Funds | Director/Board Member General Counsel | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
| OREXO AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Carnegie Investment Bank AB
 Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| University of Stockholm | College/University | Undergraduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
IMED AB
 IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Director/Board Member | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Founder Chief Tech/Sci/R&D Officer | |
| Karobio Usa | Corporate Officer/Principal | ||
| Professional Genetcis Laboratory AB | Chief Executive Officer | ||
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chairman | |
| NEOS AB | Medical Specialties | Chairman Director/Board Member | |
| MIGO OPPORTUNITIES TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer Director/Board Member Chief Investment Officer General Counsel Corporate Officer/Principal General Counsel | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | Investment Managers | Founder Analyst-Equity | |
Spinemedical AB
 Spinemedical AB Medical/Nursing ServicesHealth Services Spinemedical AB provides surgical treatment and rehabilitation services. The private company is based in Stockholm, Sweden. | Medical/Nursing Services | Director/Board Member | |
Lpb Sweden AB
 Lpb Sweden AB Real Estate DevelopmentFinance Lpb Sweden AB provides movable and immovable property services. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Lpb Sweden Holding AB
 Lpb Sweden Holding AB Real Estate DevelopmentFinance Lpb Sweden Holding AB is a Swedish company that owns and manages movable and immovable properties. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Bild & Forskning L & L Handelsbolag
 Bild & Forskning L & L Handelsbolag Miscellaneous Commercial ServicesCommercial Services Bild & Forskning L & L Handelsbolag provides biotechnology research and development services. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Demban Förvaltning AB
 Demban Förvaltning AB Real Estate DevelopmentFinance Demban Förlatning AB is a private company based in Stockholm, Sweden that provides real estate services. | Real Estate Development | Director/Board Member |
Statistics
International
| Sweden | 43 |
| United Kingdom | 5 |
| Denmark | 3 |
| United States | 3 |
Sectoral
| Health Technology | 22 |
| Finance | 10 |
| Commercial Services | 9 |
| Consumer Services | 6 |
| Miscellaneous | 3 |
Operational
| Director/Board Member | 211 |
| Chairman | 65 |
| Corporate Officer/Principal | 63 |
| Independent Dir/Board Member | 50 |
| Chief Executive Officer | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Eugen Steiner | 44 |
| Johan Rutger Christenson | 35 |
| Bo Jesper Hansen | 34 |
| Torbjørn Bjerke | 27 |
| Gisela Marie Sitbon | 26 |
| Karl Härfstrand | 23 |
| Houman Ashrafian | 22 |
| Terje Kalland | 20 |
| Hans-Peter Torsten Ekre | 16 |
| Alan Henry Clifton | 16 |
| Caroline Gulliver | 15 |
| Michael Mendelsohn | 14 |
| Patrick John Magee | 12 |
| John Aston | 12 |
| Lars Gunnar Lannfelt | 11 |
- Stock Market
- Insiders
- Carl Harald Janson
- Company connections
